Welcome to the GENESIS Pharma website.

In 1997, based on the vision of engaging in progressive and innovative commercial activity, GENESIS Pharma took full advantage of new developments in pharmaceutical biotechnology. Today, these developments are based on research and knowledge on the human genetic code (DNA) and produce innovative medicines for the treatment of medical conditions that could not be treated in the past. The development in biotechnology was our inspiration.

Since then, GENESIS Pharma has been a partner of choice of some of the leading multinational biopharmaceutical companies, such as Amgen, Biogen Idec, Celgene, Cephalon, Pharmamar, Shire and Vifor, for the sale and marketing of biopharmaceutical products in multiple specialty therapeutic areas, mainly for the treatment of chronic, life-threatening and rare diseases. We invite you to explore our website, and hope you will find it a useful as well as a stimulating tool in order to learn more about our company, our principles and the areas of our expertise.

Sincerely,

On behalf of GENESIS Pharma's Board of Directors

Alex Jacovides                        Costas Evripides
President                               C.E.O.